000 01400 a2200337 4500
005 20250517002607.0
264 0 _c20150401
008 201504s 0 0 eng d
022 _a1560-7917
024 7 _a10.2807/1560-7917.es2014.19.44.20948
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGefenaite, G
245 0 0 _aDid introduction of pneumococcal vaccines in the Netherlands decrease the need for respiratory antibiotics in children? Analysis of 2002 to 2013 data.
_h[electronic resource]
260 _bEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
_cNov 2014
500 _aPublication Type: Journal Article
650 0 4 _aAnti-Bacterial Agents
_xtherapeutic use
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aDrug Prescriptions
_xstatistics & numerical data
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aMale
650 0 4 _aNetherlands
650 0 4 _aPneumococcal Infections
_xprevention & control
650 0 4 _aPneumococcal Vaccines
_xtherapeutic use
700 1 _aBijlsma, M J
700 1 _aBos, H J
700 1 _aHak, E
773 0 _tEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
_gvol. 19
_gno. 44
856 4 0 _uhttps://doi.org/10.2807/1560-7917.es2014.19.44.20948
_zAvailable from publisher's website
999 _c24351903
_d24351903